Choice of immunotherapy vs targeted therapy in first line (BRAF)

Date 27 September 2014
Event ESMO 2014
Session Immunotherapy or targeted therapy for oncogene addicted melanoma
Topics Anticancer agents
Immunotherapy
Skin Cancers
Therapy
Biological Therapy
Presenter James Larkin
Authors J. Larkin
  • Department Of Medicine, Royal Marsden Hospital, SW3 6JJ - London/GB